Reported about 15 hours ago
Regencell Bioscience Holdings experienced a dramatic 250% surge in its stock price following a 38-to-1 stock split that took effect on June 16, 2025. This biotech company, which focuses on treating children's diseases with traditional Chinese medicine, announced the split on June 2 to improve market liquidity and accessibility for investors.
Source: YAHOO